A proof-of-concept study shows that cancer-linked RNA can be detected in wastewater, raising the possibility of tracking colorectal cancer patterns across communities without relying on individual ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Pelareorep treatment drives coordinated immune activation and tertiary lymphoid structure formation Translational data suggest potential to boost response to immunotherapy and targeted therapy in ...
Fruits are one of the best sources of nutrients to reduce chronic inflammation, which has been linked to heart disease, ...
Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...
Cancer patients who could be kept alive years longer are dying after missing out on targeted therapies amid widespread inequities in Australia’s drug access systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results